We are live on ! Find out more
TIL icon

Instil Bio

73 hedge funds and large institutions have $60.9M invested in Instil Bio in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more call options, than puts

Call options by funds: $11K | Put options by funds: $1K

15% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.37% less ownership

Funds ownership: 3.92%3.55% (-0.37%)

5% less capital invested

Capital invested by funds: $64M → $60.9M (-$3.16M)

6% less funds holding

Funds holding: 7873 (-5)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
23
Reduced
20
Closed
13
Calls
$11K
Puts
$1K
Net Calls
+$10K
Net Calls Change
+$8K

TIL Hedge Fund Activity: Q1 2023 in Review

73 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q1 2023, worth a combined $60.9M — down 4.9% from $64M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of TIL and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 23 added.

The largest buyer was Citigroup, adding an estimated $2.98M. The largest seller was Fidelity Investments, cutting an estimated $9.06M.

  • 73 institutional investors held Instil Bio (TIL) as of Q1 2023, down from 78 in Q4 2022.
  • Funds reported $60.9M of Instil Bio stock for Q1 2023, down 4.9% quarter-over-quarter.
  • 8 funds opened new Instil Bio positions in Q1 2023 and 13 closed out, a net change of -5 holders.
  • The largest Instil Bio buyer in Q1 2023 was Citigroup, an estimated $2.98M added.
  • The largest Instil Bio seller in Q1 2023 was Fidelity Investments, an estimated $9.06M sold.

Based on aggregated 13F filings for Q1 2023.